Nestle Health Science Buying Prometheus Laboratories

The deal is a "strategic move into gastrointestinal diagnostics," and will accelerate development of diagnostics in oncology and possibly other therapeutic areas.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories